Brief: PAVmed Regains Compliance With Nasdaq Stockholders' Equity Requirement
Feb 18 (Reuters) - Lucid Diagnostics Inc LUCD.O :
* PAVMED REGAINS COMPLIANCE WITH NASDAQ STOCKHOLDERS' EQUITY
REQUIREMENT
Source text: ID:nPn3lvNcFa
Further company coverage: LUCD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lucid Diagnostics
See all newsLucid Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Lucid Diagnostics Inc expected to post a loss of 7 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks
U.S. STOCKS ON THE MOVE- American Airlines, Pot stocks, Paramount Skydance
Lucid Diagnostics falls on $18 mln direct stock deal